Software pro vizualizaci onkologických dat (SVOD), www. svod.cz.
Van Cutsen E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009; 360: 1408-1417.Go to original source...Go to PubMed...
Bokemeyer C, Bondarenko I, Makhson A, et al. Fluorouracil, leucovorin and oxaliplatin with and without cetuximab inthe first line treatment of metastatic colorectal cancer. J Clin Oncol 2009; 27: 663-671.Go to original source...Go to PubMed...
Saltz LB, Clarke S, Díaz-Rubio E, et al. Bevacizumab in combination wit oxaliplatin based chemotherapy as first line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 2008; 26: 2013-2019.Go to original source...Go to PubMed...
Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liber metastase from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996; 224: 509-522.Go to original source...Go to PubMed...
Adam R, Wicherts DA, de Haas RJ, et al. Patient wit initially unresectable colorectal liver metastase: is there a posibility of cure? J Clin Oncol 2009; 27: 1829-1835.Go to original source...Go to PubMed...
Nordlinger B, Skrbte H, Glimelius B, et al. Preoperative chemotherapy whith FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomized controlled trial. Lancet 2008; 371: 1007-1016.Go to original source...Go to PubMed...
Kubala E, Bartoš J, Petruželka L, et al. Safety and effectivness of bevacizumab in combination with chemotherapy in patients with metastatic colorectal cancer in eldery population: updated results from a large Czech observational registry. ASCO GI 2010.
Madam, Sir, please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert). Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.
I declare:
that I have met the above instruction
I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited